[Diabetes, obesity and heart complications]
Related Experiment Video
Updated: May 9, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
François Picard1, Pierre dos Santos, Bogdan Catargi
1Services de cardiologie et d'endocrinologie-diabétologie, Hôpital du Haut-Lévêque, CHU de Bordeaux, 33000 Bordeaux, France.
Insights
Intensive blood sugar control benefits newly diagnosed type 2 diabetes patients long-term. For established diabetes, multifactorial risk reduction is key for preventing cardiovascular disease and heart failure.
Area of Science:
- Endocrinology
- Cardiology
- Public Health
Context:
- Epidemiologic studies link chronic hyperglycemia to cardiovascular disease.
- Randomized trials lack evidence for intensive therapy benefits in long-standing type 2 diabetes macrovascular outcomes.
- Obesity and hyperglycemia increase cardiovascular risk, even outside diabetic ranges.
Purpose:
- To review the evidence on intensive glycemic control and macrovascular outcomes in type 2 diabetes.
- To highlight the importance of multifactorial risk reduction for cardiovascular complications.
- To emphasize the independent risk of diabetes and obesity for heart failure and cardiomyopathy.
Summary:
- Intensive glycemic control shows long-term benefits for macrovascular outcomes in newly diagnosed type 2 diabetes.
- No convincing evidence supports intensive therapy for macrovascular benefits in long-standing type 2 diabetes.
- Multifactorial risk reduction is crucial for preventing cardiovascular disease and heart failure in diabetic patients.
- Obesity and diabetes independently increase heart failure risk and can cause cardiomyopathy.
Impact:
- Recommends a multidisciplinary approach for managing diabetes-related cardiovascular complications.
- Underscores the need for early and comprehensive risk factor management in type 2 diabetes.
- Informs clinical practice regarding glycemic control targets and risk reduction strategies.
Abstract:
Although epidemiologic analyses suggest a correlation between higher rates of cardiovascular disease and chronic hyperglycemia, to date, no randomized clinical trial has convincingly demonstrated a beneficial effect of intensive therapy on macrovascular outcomes in individuals with long-standing type 2 diabetes. In contrast, intensive initial control in individuals with newly diagnosed diabetes has long-term benefit in decreasing the risk of myocardial infarction, diabetes-related death, and overall death. There is strong, consistent evidence that the relationship between blood glucose levels and cardiovascular risk extends into the no diabetic range and obesity. Therefore, multifactorial risk reduction should be a top priority for prevention of macrovascular complications. We should keep in mind that obesity and diabetes also increase the risk of heart failure independent of coronary heart disease and hypertension and may cause a cardiomyopathy, a frequent, forgotten, and often fatal complication. This multifactorial disease should be treated by a multidisciplinary team.
More Related Videos
Related Concept Videos
Complications of Diabetes Mellitus
Type II Diabetes II: Pathophysiology
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes I: Introduction
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational

